CARUSO, RAFFAELE
 Distribuzione geografica
Continente #
AS - Asia 1.050
NA - Nord America 692
EU - Europa 234
SA - Sud America 178
AF - Africa 17
OC - Oceania 1
Continente sconosciuto - Info sul continente non disponibili 0
Totale 2.172
Nazione #
US - Stati Uniti d'America 656
SG - Singapore 448
CN - Cina 227
BR - Brasile 139
HK - Hong Kong 111
VN - Vietnam 110
NL - Olanda 60
FR - Francia 50
KR - Corea 35
IT - Italia 34
BD - Bangladesh 33
FI - Finlandia 22
JP - Giappone 20
GB - Regno Unito 15
IN - India 13
AR - Argentina 11
CA - Canada 10
MX - Messico 10
DE - Germania 9
ID - Indonesia 9
IQ - Iraq 7
MA - Marocco 6
VE - Venezuela 6
ZA - Sudafrica 6
EC - Ecuador 5
HR - Croazia 5
IL - Israele 5
SA - Arabia Saudita 5
UA - Ucraina 5
UY - Uruguay 5
JM - Giamaica 4
PL - Polonia 4
RS - Serbia 4
UZ - Uzbekistan 4
DO - Repubblica Dominicana 3
IE - Irlanda 3
NI - Nicaragua 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
ES - Italia 2
GP - Guadalupe 2
GY - Guiana 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
PH - Filippine 2
RU - Federazione Russa 2
TR - Turchia 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 2.172
Città #
Singapore 247
Santa Clara 217
Hong Kong 110
Hefei 89
San Jose 75
Beijing 64
Ashburn 53
Lauterbourg 43
Ho Chi Minh City 35
Seoul 35
Los Angeles 34
Hanoi 25
Helsinki 22
New York 16
Tokyo 16
São Paulo 15
Buffalo 11
Dallas 11
Orem 9
Guangzhou 6
Rome 6
Atlanta 5
Milan 5
Montevideo 5
Naples 5
Phoenix 5
Santo André 5
Belgrade 4
Belo Horizonte 4
Biên Hòa 4
Brooklyn 4
Caracas 4
Haiphong 4
Kingston 4
Milwaukee 4
Minamishinagawa 4
Philadelphia 4
Porto Alegre 4
Rio de Janeiro 4
Tashkent 4
Thái Bình 4
Toronto 4
Warsaw 4
Baghdad 3
Bengaluru 3
Buenos Aires 3
Cape Town 3
Curitiba 3
Elk Grove Village 3
Falkenstein 3
Florence 3
Frankfurt am Main 3
Johannesburg 3
London 3
Managua 3
Nam Định 3
Piscataway 3
Tampa 3
Aracaju 2
Arapiraca 2
Batavia 2
Bauru 2
Betim 2
Bishkek 2
Boituva 2
Brasília 2
Buon Ma Thuot 2
Bắc Giang 2
Cachoeiras de Macacu 2
Casablanca 2
Cascina 2
Chesapeake 2
Chicago 2
Covina 2
Dublin 2
Effingham 2
Erlanger 2
Fortaleza 2
Ft. Pierce 2
Georgetown 2
Guarulhos 2
Guayaquil 2
Harrisburg 2
Irving 2
Itaquaquecetuba 2
Jeddah 2
Kyiv 2
La Paz 2
Lagos 2
Lima 2
Louisville 2
Maracaibo 2
Montreal 2
Mumbai 2
Nairobi 2
Newark 2
North Hollywood 2
Nova Iguaçu 2
Nuremberg 2
Orlando 2
Totale 1.362
Nome #
Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients 99
Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: Evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support. 83
C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity 81
Adrenomedullin and intermedin gene transcription is increased in leukocytes of patients with chronic heart failure at different stages of the disease (Peptides (2014) 55 (13-16)) 79
Upregulation of chemokine receptor CXCR4 and caspase-dependent apoptosis genes can synergistically favour activation of endothelial cells exposed to low shear stress 71
CNP transcriptomic profiling in HF patients as a function of clinical severity 58
C-TYPE NATRIURETIC PEPTIDE TRANSCRIPTOMIC PROFILING INCREASES IN LEUKOCYTES OF PATIENTS WITH CHRONIC HEART FAILURE AS A FUNCTION OF CLINICAL SEVERITY 57
Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein. 55
Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device 53
Left Ventricular Assist Device Activates the Transcriptional Apoptotic Profile in Human Heart 52
Early Expression of Pro- and Anti-Inflammatory Cytokines in Left Ventricular Assist Device Recipients With Multiple Organ Failure Syndrome 51
La malattia del microcircolo coronarico nella disfunzione ventricolare sinistra: dai modelli sperimentali alla clinica. 48
A Decision Support System for the Treatment of Patients with Ventricular Assist Device Support 48
Report on Task 3.3 activities Clinical research on biomarkers 47
Time-course of plasma NT-pro C-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 46
Relationship between Early Inflammatory Response and Clinical Evolution of the Severe Multiorgan Failure in Mechanical Circulatory Support-Treated Patients 46
PLASMA ADIPONECTIN LOWERING AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS ASSOCIATED WITH 1-MONTH SURVIVAL IN PATIENTS WITH ADVANCED HEART FAILURE 45
Differential Regulation of MicroRNAs in End-Stage Failing Hearts Is Associated with Left Ventricular Assist Device Unloading 45
Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation 45
Lo stress ossidativo e l'attivazione dell'infiammazione nello scompenso cardiaco terminale non migliorano durante la prima fase (1 mese) dopo impianto di assistenza ventricolare meccanica sinistra (LVAD) 44
LEFT VENTRICULAR ASSIST DEVICE ACTIVATES THE TRANSCRIPTIONAL APOPTOTIC PROFILE IN HUMAN HEART 44
Plasma Adiponectin Lowering after left Ventricular Assist Device Implantation is Associated with 1-Month Survival in Patients with Advanced Heart Failure 44
Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients. 43
IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: A paradoxic role for inflammatory mediators? 40
Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide. 40
Osteopontin plasma levels increase in end-stage heart failure patients supported by left ventricular assist device implant. 39
Homo sapiens natriuretic peptide C (NPPC), mRNA (NCBI Reference Sequence: NM_024409.2) 39
Osteopontin plasma levels increase in end-stage heart failure patients supported by left ventricular assist device implant. 39
Critical study of preanalytical and analytical phase of adenine and pyridine nucleotide assay in human whole blood. 39
Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure 38
High peripheral levels of h-FABP are associated with poor prognosis in end-stage heart failure patients with mechanical circulatory support 38
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 37
A novel biosensor based on hafnium oxide: Application for early stage detection of human interleukin-10 36
Plasma glutathione levels are independently associated with ?-glutamyltransferase activity in subjects with cardiovascular risk factors 35
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant 35
A Novel Three-Dimensional Biosensor Based on Aluminum Oxide: Application for Early-Stage Detection of Human Interleukin-10 34
Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance 33
Oxidative stress and inflammatory activation in end-stage heart failure do not ameliorate during early phase (1 month) of left ventricular mechanical assistance 33
Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs normohomocysteinemia 33
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist device implantation 33
Reduced myocardial MMP-2, MMP-9 and gluatione peroxidase activities and elevated cytokine levesl in patients supported by left ventricular assist device 32
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist 31
The role of PON2 311 Cys allele and risk factors in atherothrombotic event 29
Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure? 29
Myocardial redox state alterations and elevated cytokines levels in patients with end stage heart failure (ESHF) supported by left ventricular assist device (LVAD) 26
Reduction of cardiac metalloproteinase activity is sustained by amelioration of GSH bioavailability during left ventricular assist device support in failing heart. 26
Sample carryover in PT-INR determination Is it an issue in Oral Anticoagulant Therapy control? 24
Simultaneous determination of plasma levels and cardiac expression of CNP in end-stage heart failure patients undergoing left ventricular assist devices 24
PON2 S311C polymorphism and risk factors are independently associated with atherothrombotic events 23
Plasma Total Cysteine and Cardiovascular Risk Burden: Action and Interaction 23
Totale 2.172
Categoria #
all - tutte 7.237
article - articoli 5.825
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 459
Totale 13.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 1 0 0 5 0
2024/2025867 6 1 81 31 164 67 20 32 38 67 199 161
2025/20261.230 55 91 104 166 277 66 198 42 31 74 93 33
2026/202769 69 0 0 0 0 0 0 0 0 0 0 0
Totale 2.172